5 active not recruiting. 5 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Active not recruiting 5 |
| Phase 3 | 3 | Active not recruiting 3 |
Follow Alcohol Drinking: new trials by email Literature Review of Alcohol Drinking trials Research Report on Alcohol Drinking
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Ketone Supplement and Alcohol on Brain Metabolism Kenetik, Alcohol beverage - Ketosis, Alcohol Drinking | Phase 2 / Phase 3 | Active not recruiting | University of Pennsylvania | 60 | 2025-05-13 | 2026-10-14 |
| Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder Oral solution - Alcohol Use Disorder | Phase 2 | Active not recruiting | Centre for Addiction and Mental Health | 36 | 2024-08-16 | 2026-11-02 |
| Effect of Nutritional Ketosis on Alcohol Metabolism Ketone Supplement, Control Diet, Ketogenic diet - Ketoses, Metabolic, Ketogenic Dieting | Phase 2 / Phase 3 | Active not recruiting | University of Pennsylvania | 23 | 2024-02-29 | 2026-04-07 |
| Gabapentin to Reduce Alcohol and Improve Viral Load Suppression Gabapentin, Placebo - HIV, Heavy Drinking | Phase 2 | Active not recruiting | Boston Medical Center | 220 | 2023-11-20 | 2026-11-05 |
| Acute Effects of Ketone Supplement on Responses to Alcohol Challenge in Healthy Volunteers Ketone Supplement, Alcohol Beverage - Alcohol Drinking | Phase 2 / Phase 3 | Active not recruiting | University of Pennsylvania | 10 | 2022-10-20 | 2026-08-06 |
Ketosis (2) · Alcoholic Intoxication (1) · Alcoholism (1)
Behavior (5) · Drinking Behavior (5) · Acid-Base Imbalance (2) · Acidosis (2) · Alcohol-Related Disorders (2) · Chemically-Induced Disorders (2) · Mental Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Substance-Related Disorders (2)
Ethanol (3) · 1,3-butylene glycol (1) · Diet, Ketogenic (1) · Gabapentin (1) · Solutions (1)
University of Pennsylvania (3) · Boston Medical Center (1) · Centre for Addiction and Mental Health (1)
United States (3) · Canada (1) · Uganda (1)
Corinde Wiers, Ph.D. (2) · Corinde Wiers, PhD (1) · Henry Kranzler, MD (1) · Jeffrey Samet, MD MA MPH (1) · Karsten Lunze, MD MPH DrPH (1) · Kyle Kampman, MD (1) · Matthew Sloan, MD (1)
R21AA031088 (2), R01AA030460 (1)